Gut-derived bacterial vesicles carrying lipopolysaccharide promote microglia-mediated synaptic pruning.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and in vitro mechanistic study with human case-control biofluid sampling
PubMed 40731189 · doi:10.1002/alz.70331
What was done
Bacterial extracellular vesicles (bEVs) were isolated from human and mouse feces and blood to measure lipopolysaccharide (LPS) levels. In vivo imaging and immunofluorescence assessed whether blood LPS-carrying bEVs crossed the blood-brain barrier (BBB). The effects of bEVs on microglial activation and Piezo1 involvement were investigated in vivo and in vitro, alongside comparisons of plasma LPS-containing bEVs between Alzheimer's disease (AD) patients and healthy controls.
What was found
Elevated LPS-containing bEVs were detected in the plasma of AD patients compared to healthy individuals, but the abstract reports no specific numerical concentrations or statistical metrics. In experimental models, LPS was necessary for bEV penetration across the BBB. Within the brain, bEVs activated microglial Piezo1, precipitating excessive synaptic pruning mediated by the C1q-C3 complement pathway.
Why it matters
This work identifies a specific transport vehicle (bEVs) and molecular pathway (Piezo1 and C1q-C3) by which gut microbial components breach the blood-brain barrier to drive early synaptic pathology in Alzheimer's disease.
Limits
The abstract reports no sample sizes (n) for human cohorts, animal subjects, or cellular assays, and provides no quantitative data, effect sizes, or confidence intervals. Causal mechanisms linking bEVs to synaptic pruning rely on preclinical models, leaving clinical translation and disease progression links correlational. Specific bacterial taxa contributing to pathogenic bEV production were not detailed.
Cited by
- supports Microglial activation triggered by gut permeability and inflammatory cytokines leads to synaptic and dendritic degradation in the brain.